Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595030 · ClinicalTrials.gov registry record · NA
Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT06595030 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 101 participants.
The verdict
NCT06595030, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 participants who will experience either the active TLI or the placebo for 6 months.
Interventions
- DEVICE Active Lighting Intervention
- DEVICE Control Lighting Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2024-12-03 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06595030
The ClinicalTrials.gov registry entry for NCT06595030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Lighting Intervention is the first listed.
NCT06595030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06595030 about?
NCT06595030 is a clinical study titled "Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3". Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 par...
What is the current status of trial NCT06595030?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2024-12-03. Estimated completion is 2026-01-31.
What interventions are being tested in trial NCT06595030?
The interventions under investigation include: Active Lighting Intervention (DEVICE), Control Lighting Intervention (DEVICE).
Who is sponsoring clinical trial NCT06595030?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.